ECE 2007 - Budapest, 28 April -2 May 2007

The 9th European Congress of Endocrinology is now only days away. The ECE 2007 is being hosted by the Hungarian Society of Endocrinology and Metabolism and will be held at Papp Lászlό Budapest Sportaréna, H-1143 Budapest, Stefánia út 2. Hungary from 28 April until 2 May 2007. Attendees are expected from all over the world to learn from the latest advances in endocrine research and clinical care presented by the thought leaders in the field. The POC has actively worked to put together a programme of scientific excellence that will be attractive to all professionals interested in endocrinology and metabolism. The on-line registration form is available at the link below. For further information, please visit the ECE 2007 conference website.

On-line registration form

ECE 2007

On-line abstracts now available for ECE 2007

On-line abstracts for the 9th European Congress of Endocrinology, 28th April - 2nd May 2007, are now available on their website. Please follow the link below.

ECE 2007

Membership Applications

Every application for membership must be formally approved by the ESE Executive Committee and by the full membership at each Annual General Meeting. The next AGM will be held on 1 May 2007 at the ECE 2007 in Budapest. Members who will be approved at this AGM are listed on the website link below. Please note, if your name appears on the "Members for election (incomplete details)" list, please contact the ESE Secretariat at info@euro-endo.org to check what information is missing from your application.

2007 Members for Election

E-Vote for Election to the ESE Executive Committee

The E-vote closed on 18 April 2007. The results of the voting will be announced at the Annual General Meeting, to be held at the ECE 2007, Budapest, on Tuesday 1 May 2007.

Online Membership Renewal

Membership payments for 2007 can be made online. Before making payment you will need to obtain a password. You can find full instructions on how to do this by following the link below.

Membership Renewal

2007 ESE Annual General Meeting

The next ESE AGM will be held on Tuesday 1 May 2007 at the ECE 2007 in Budapest. The agenda has been circulated to members but if you would like to receive a copy, please contact the ESE Secretariat on info@euro-endo.org.

ECE 2008

The 10th European Congress of Endocrinology will be hosted by the German Endocrine Society and will be held at the ICC in Berlin, 3 - 7 May 2008. Further details will be available at the link below.

ECE 2008

European Research Area

The European Commission has launched a debate on the European Research Area with the adoption of the ERA Green Paper. The ERA Green Paper reviews the progress made, where it still needs to be made and raises questions for debate. An online consultation on this will be launched on 1st May 2007

European Research Area

French doctors charged over growth hormone deaths (Sydney Morning Herald, 11 April 2007)

Seven French doctors have been ordered to stand trial over the deaths of 110 children who developed Creutzfelt-Jakob Disease after being prescribed growth hormones in the 1980s.

Full article

Weight-Loss Surgery Reduces Insulin Resistance, Improves Beta Cell Function (Medical News Today, 2 April 2007)

In severely obese people, surgery to reduce the amount they eat reduces their insulin resistance and improves their beta cell function, regardless of whether they lose any weight.

Full article

Gene test 'targets cancer drug' (BBC News Online, 10 April 2007)

A study in Nature Genetics suggests that testing for a gene called ESR1 can show which women with breast cancer would benefit most from oestrogen-blocking drugs. Women with more copies of the gene had tumours that were more likely to respond to tamoxifen.

Full article

Measuring calcium intake can help to identify osteoporosis in men with prostate cancer (AlphaGalileo, 10 April 2007)

Research published in the urology journal BJU International shows that measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis.

Full article

Arthritis Drug Helps With Type 2 Diabetes (Medical News Today, 16 April 2007)

A drug, normally used to treat rheumatoid arthritis, may help people with type 2 diabetes.

Full article

Symposium calls for increased co-operation in fight against doping in sport (World Anti-Doping Agency, 17 April 2007)

An international symposium of government, sport, anti-doping and law enforcement authorities has called for the targeting of wide scale doping schemes involving the illegal manufacture and distribution of performance enhancing drugs. They urged for increased cooperation between governments and law enforcement agencies around the world to combat this problem.

Full Article

Sick leave in thyroid cancer patients

Traditionally, TSH stimulation in recovering thyroidectomy patients has been achieved using thyroid hormone withdrawal (THW); this often results in hypothyroidism, lowered quality of life and the taking of sick leave. rhTSH (Thyrogen®) is a modern equivalent for this. In their study, Borget et al seek to quantify the economic and budgetary effects of each treatment using the number of sick-leave days taken as a measure for comparison. Patients were recruited both prospectively and retrospectively; in total, 292 patients completed and returned a questionnaire, which formed the basis of the analysis. The calculated impact of taking sick leave was estimated to be €27 per day from the National Sickness Fund, and €193 of lost productivity per day upon the economy, for people of working status. The study found that patients treated with rhTSH were less likely to require sick leave either before or after the control point, and sick leave duration was also shorter in these patients. Indirect costs of sick leave were also seen to reduce by €1083 when rhTSH was used. The group conclude that compared to THW, rhTSH treatment is comparable in terms of diagnostic accuracy of disease recurrence; it avoids hypothyroidism and thus lowers the requirement for sick leave, reducing costs for patients and society. Borget I, Corone C, Nocaudie M, Allyn M, Iacobelli S, Schlumberger M, De Pouvourville G. European Journal of Endocrinology 156 531-538

Specialist Physician in Urology or Endocrinology

Department of Urology, San Paolo University, Italy. The department deals with male infertility and all male genital pathologies - erectile dysfunction and other sexual disorders included - both medically and surgically. It includes a Seminology Laboratory with annexed Semen Bank and an Embryology Laboratory. All this is integrated into an Infertility Center with a Section for Assisted Reproductive Technology. Prerequisites for the job: Previous clinical experience in the above-mentioned areas, English Language, citizenship of a European Community member country. Optional, preferential requirements: Experience in ultrasonographic diagnosis of the male genital apparatus, at least partial knowledge of the Italian language. Applicants should send their CVs to the following e-mail addresses: gpiediferro@libero.it and gmcolpi@yahoo.com. Further information about the department and the Head Physician, (search for Giovanni Colpi), can be found via the links below.

University

Head Physician

International Medical Affairs Manager, HRA Pharma, Paris, France

Language needed: English. Area: Niche products/ Orphan drugs in Endocrinology. The medical affairs manager will be the internal expert for the existing portfolio and for future projects in the field. International Key Opinion Leaders management. Transversal activity, interaction with R&D, regulatory, pharmacovigilance & marketing departments. The profile is for a physician ideally specialised in endocrinology. First experience (either clinical or industrial) would be appreciated. For more information contact: François Vuillet at Laboratoire HRA Pharma, 15 rue Béranger 75003 PARIS, France. Phone: 00 33 1 40 33 11 30. Fax : 00 33 1 42 77 18 83. Email : f.vuillet@hra-pharma.com or visit the website below.

Website

Franco-British Research Collaboration: Alliance 2008 - Call for proposals

This year's call for proposals under the Franco-British research partnership programme Alliance is now open. The deadline for applications is Friday 1 June 2007. Alliance is a programme run jointly by the British Council and the French Ministries of Foreign Affairs and Research. Funding is available to cover the travel and subsistence costs of new research collaborations from any discipline involving universities and public sector research institutes. Grants are awarded for one year, renewable for a second year. There are currently around 80 "live" Alliance projects, and it is expected that 30 to 40 new projects will be launched in 2008. Full details about the scheme and application form are available from the link below. The scheme is administered for the UK by the British Council's office in France. If you have any questions, contact alliance@britishcouncil.fr or phone Sandrine Mahieu, Tel: +33 (0)1 49 55 73 32.

Link to Alliance Programme

British Council: A Call for Proposals

The British Council is announcing a call for proposals under its initiative aimed at supporting new links between early stage researchers in the UK and in other countries. The purpose of the Researcher Exchange Programme is to help develop new research links between higher education institutions and research laboratories in the UK and other countries. It aims to encourage mobility and internationalism among early stage researchers for the exchange of information, ideas and knowledge, and for relationship-building. Closing date: 2 June 2007

Link

The Graduiertenkolleg GRK 1208 'Hormonal Regulation of Energy Metabolism, Body Weight and Growth' invites applications for a PhD Scholarship

The position will be available from July, 2007, in the group of Clinical Endocrinology. The research will be focusing on determination and characterization of molecular isoforms as well as mutants of human growth hormone and study of their modulation during life span and in pathophysiological conditions, as well as its consequences for insulin sensitivity. The laboratory is well equipped with devices such as Biacore-biosensor and Typhoon fluorescent imager. The modern molecular biological, immunological and hormone analytical methods will be used. The Graduiertenkolleg GRK 1208 is an interdisciplinary research, study and training program (in English) of Humboldt-Universität & Freie Universität Berlin, supported by the Deutsche Forschungsgemeinschaft (DFG) and the State of Berlin, focusing on molecular, cellular & clinical endocrinology. The research training position is open for students under 28 years of age with an excellent study record and a Diploma or Master's degree (or equivalent) in biology, biochemistry, cell biology, molecular biology, chemical biology, molecular medicine, etc. The PhD scholarships can be awarded for up to 2 years with one possible extension by 6 months. Applications (English/German) including a one-page statement of motivation, a full CV, summary of the master/diploma thesis, copies of your credentials and names and addresses of two referees should be submitted by e-mail to Prof. Dr. J. Köhrle (secretary: Mrs. Elke Abdel-Karim: elke.abdelkarim@charite.de).

Institut für Experimentelle Endokrinologie

Job advert web address

If you have any feedback on the content of the alert, email: jo.thurston@endocrinology.org

Please feel free to pass this email alert on to anyone you think may be interested.